drugset / Trial / NCT04596995
A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the long-term safety, tolerability and clinical efficacy of treatment with rozanolixizumab.
Timeline
- Start
- 2021-01-06
- Primary completion
- 2022-12-21
- Completion
- 2022-12-21
Outcome
Outcome not reported
Stopped (Business): “Strategic Business Decision; Not a safety decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rozanolixizumab | Monoclonal antibody | — | Subcutaneous |